文献速递胸部技术与安全CTPET

人工智能预测非小细胞肺癌EGFR突变状态的系统评价与Meta分析

Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer Using Artificial Intelligence: A Systematic Review and Meta-Analysis.
PubMed 文献 · Acad Radiol · 2023-04-28

AI算法总体AUC为0.789,汇总敏感度和特异度分别为72.2%和73.3%;深度学习算法AUC(0.822)和敏感度(80.1%)优于传统机器学习,但特异度较低(70.0% vs 73.8%,P<0.001)。结论认为深度学习算法有潜力提高预测准确性,并建议制定医学影像AI分析指南。

要点

  • AI算法预测NSCLC EGFR突变总体AUC 0.789,敏感度72.2%,特异度73.3%。
  • 深度学习AUC 0.822、敏感度80.1%,优于传统机器学习,但特异度较低。
  • PET/CT、附加临床信息、深度特征提取和手动分割可提高诊断性能。

核心结论

  • 深度学习算法可作为提高EGFR突变预测准确性的新方法,在预测NSCLC患者EGFR突变状态方面具有较大潜力。
  • 建议制定医学图像分析中使用AI算法的指南,重点关注肿瘤影像组学。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、EMBASE、Web of Science和IEEExplore截至2022年2月28日的研究。
  • 纳入使用传统机器学习或深度学习算法预测NSCLC患者EGFR突变的研究,研究已注册PROSPERO(CRD42021278738)。

诊断标准与关键数值

  • AI算法总体AUC为0.789,汇总敏感度72.2%,汇总特异度73.3%。
  • 深度学习算法AUC为0.822、敏感度80.1%,传统机器学习AUC为0.775、敏感度71.1%。
  • 深度学习算法特异度为70.0%,传统机器学习特异度为73.8%,差异P<0.001。

临床应用与阅片要点

  • PET/CT、附加临床信息、深度特征提取和手动分割与更好的诊断性能相关,阅片和建模时可优先考虑。
  • 深度学习敏感度较高但特异度较低,报告时应结合临床背景解读阳性预测价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Recent advancements in artificial intelligence (AI) render a substantial promise for epidermal growth factor receptor (EGFR) mutation status prediction in non-small cell lung cancer (NSCLC). We aimed to evaluate the performance and quality of AI algorithms that use radiomics features in predicting EGFR mutation status in patient with NSCLC.

MATERIALS AND METHODS: We searched PubMed (Medline), EMBASE, Web of Science, and IEEExplore for studies published up to February 28, 2022. Studies utilizing an AI algorithm (either conventional machine learning [cML] and deep learning [DL]) for predicting EGFR mutations in patients with NSLCL were included. We extracted binary diagnostic accuracy data and constructed a bivariate random-effects model to obtain pooled sensitivity, specificity, and 95% confidence interval. This study is registered with PROSPERO, CRD42021278738.

RESULTS: Our search identified 460 studies, of which 42 were included. Thirty-five studies were included in the meta-analysis. The AI algorithms exhibited an overall area under the curve (AUC) value of 0.789 and pooled sensitivity and specificity levels of 72.2% and 73.3%, respectively. The DL algorithms outperformed cML in terms of AUC (0.822 vs. 0.775) and sensitivity (80.1% vs. 71.1%), but had lower specificity (70.0% vs. 73.8%, p-value < 0.001) compared to cML. Subgroup analysis revealed that the use of positron-emission tomography/computed tomography, additional clinical information, deep feature extraction, and manual segmentation can improve diagnostic performance.

CONCLUSION: DL algorithms can serve as a novel method for increasing predictive accuracy and thus have considerable potential for use in predicting EGFR mutation status in patient with NSCLC. We also suggest that guidelines on using AI algorithms in medical image analysis should be developed with a focus on oncologic radiomics.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Nguyen, Ho, Nguyen, et al. Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer Using Artificial Intelligence: A Systematic Review and Meta-Analysis. Acad Radiol. 2023. PMID: 37120403. doi:10.1016/j.acra.2023.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。